Israel Acquisitions Corp Warrant

NASDAQ:ISRLW USA Shell Companies
Market Cap
$1.21K
Market Cap Rank
#47857 Global
#14748 in USA
Share Price
$0.13
Change (1 day)
+1.92%
52-Week Range
$0.07 - $0.33
All Time High
$0.33
About

Israel Acquisitions Corp focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on Israeli technology companies. The company was incorporated in 2021 and is based in Bee Cave, Texas. Israel Acquisitions Corp operates as a subsidiary of Israel Acquisition… Read more

Israel Acquisitions Corp Warrant (ISRLW) - Net Assets

Latest net assets as of September 2024: $75.05 Million USD

Based on the latest financial reports, Israel Acquisitions Corp Warrant (ISRLW) has net assets worth $75.05 Million USD as of September 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($81.56 Million) and total liabilities ($6.51 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $75.05 Million
% of Total Assets 92.02%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Israel Acquisitions Corp Warrant - Net Assets Trend (2021–2023)

This chart illustrates how Israel Acquisitions Corp Warrant's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Israel Acquisitions Corp Warrant (2021–2023)

The table below shows the annual net assets of Israel Acquisitions Corp Warrant from 2021 to 2023.

Year Net Assets Change
2023-12-31 $148.85 Million +286350.44%
2022-12-31 $-52.00K -927.87%
2021-12-31 $-5.06K --

Equity Component Analysis

This analysis shows how different components contribute to Israel Acquisitions Corp Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 484727200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Other Components $153.70 Million 103.26%
Total Equity $148.85 Million 100.00%

Israel Acquisitions Corp Warrant Competitors by Market Cap

The table below lists competitors of Israel Acquisitions Corp Warrant ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Israel Acquisitions Corp Warrant's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from -52,000 to 148,850,230, a change of 148,902,230.
  • Net income of 6,073,475 contributed positively to equity growth.
  • New share issuances of 148,875,000 increased equity.
  • Other factors decreased equity by 6,046,245.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income $6.07 Million +4.08%
Share Issuances $148.88 Million +100.02%
Other Changes $-6.05 Million -4.06%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Israel Acquisitions Corp Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.02x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 $0.00 $0.13 x
2022-12-31 $-0.01 $0.13 x
2023-12-31 $7.47 $0.13 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Israel Acquisitions Corp Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.08%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.04x
  • Recent ROE (4.08%) is above the historical average (2.04%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2022 0.00% 0.00% 0.00x 0.00x $-66.74K
2023 4.08% 0.00% 0.00x 1.04x $-8.81 Million

Industry Comparison

This section compares Israel Acquisitions Corp Warrant's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Israel Acquisitions Corp Warrant (ISRLW) $75.05 Million 0.00% 0.09x $1.29K
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K